Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
Left untreated, malignant pleural mesothelioma (MPM) is associated with uniformly poor prognosis. Better survival has been reported with surgery-based multimodality therapy, but to date, no trial has demonstrated survival benefit of surgery over other therapies. We evaluated whether cancer-directed...
Main Authors: | Emanuela Taioli, Andrea S Wolf, Marlene Camacho-Rivera, Andrew Kaufman, Dong-Seok Lee, Daniel Nicastri, Kenneth Rosenzweig, Raja M Flores |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4682765?pdf=render |
Similar Items
-
Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma
by: Rebecca M. Schwartz, et al.
Published: (2018-11-01) -
VATS Pleurectomy Decortication Is a Reasonable Alternative for Higher Risk Patients in the Management of Malignant Pleural Mesothelioma: An Analysis of Short-Term Outcomes
by: Dong-Seok Lee, et al.
Published: (2021-03-01) -
Malignant pleural mesothelioma
by: Rao Sukhesh
Published: (2009-01-01) -
Immunotherapy in Malignant Pleural Mesothelioma
by: Cornedine J. de Gooijer, et al.
Published: (2020-02-01) -
Malignant pleural mesothelioma: an update
by: Glaucia N. M. Hajj, et al.
Published: (2021-12-01)